We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs

3 0 0
12.08.2021

Cancer patients have been generating and maintaining high levels of antibodies from coronavirus vaccines, Israeli researchers have found.

A peer-reviewed study by doctors from Rabin Medical Center in Petah Tikva found some 87 percent of cancer patients had high antibody levels four months after vaccination.

That is a lower rate than among people with fully functioning immune systems — 100% of whom had good antibody levels — but represents a good response by cancer patients, according to the study.

“This was reassuring, in the sense that even as people are receiving cancer therapy that makes the immune system less active, there is still a good immune education that can produce antibodies,” Prof. Salomon Stemmer of the hospital’s Institute of Oncology, the study’s lead author, told The Times of Israel.

Since the study was concluded, many Israelis — some well more than four........

© The Times of Israel


Get it on Google Play